Literature DB >> 30662239

Joint replacement in X-linked hypophosphatemia.

Emily S Mills1, Louis Iorio1, Richard S Feinn1, Kevin M Duignan1, Carolyn M Macica1.   

Abstract

X-linked hypophosphatemia (XLH) is associated with a pervasive, severe degenerative osteoarthritis. We conducted a retrospective chart review/patient survey using the Knee or Hip Osteoarthritis Outcome Score Physical Function Short Form. Fourteen total knee arthroplasties and 7 total hip arthroplasties among 11 patients were included. The mean KOOS-PS score was 31.4 ± 9.7 with a mean follow up of 6.9 years. Mean HOOS-PS score was 14.8 ± 12.9 at a mean follow up of 7.6 years. One knee failed due to aseptic loosening and one hip was revised due to polyethylene wear. In conclusion, total joint arthroplasty is beneficial in XLH.

Entities:  

Keywords:  Hip arthroplasty; Knee arthroplasty; Knee or hip osteoarthritis outcome score physical function short form; Osteomalacia; Phosphate-wasting disorders; X-linked hypophosphatemia

Year:  2018        PMID： 30662239      PMCID： PMC6324762          DOI： 10.1016/j.jor.2018.12.007

Source DB:  PubMed          Journal:  J Orthop        ISSN： 0972-978X


  26 in total

1.  Combined technique for the correction of lower-limb deformities resulting from metabolic bone disease.

Authors:  M Kocaoglu; F E Bilen; C Sen; L Eralp; H I Balci
Journal:  J Bone Joint Surg Br       Date:  2011-01

2.  The development of a short measure of physical function for hip OA HOOS-Physical Function Shortform (HOOS-PS): an OARSI/OMERACT initiative.

Authors:  A M Davis; A V Perruccio; M Canizares; A Tennant; G A Hawker; P G Conaghan; E M Roos; J M Jordan; J-F Maillefert; M Dougados; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2008-03-04       Impact factor: 6.576

3.  An atypical degenerative osteoarthropathy in Hyp mice is characterized by a loss in the mineralized zone of articular cartilage.

Authors:  Guoying Liang; Joshua Vanhouten; Carolyn M Macica
Journal:  Calcif Tissue Int       Date:  2011-06-04       Impact factor: 4.333

Review 4.  A clinician's guide to X-linked hypophosphatemia.

Authors:  Thomas O Carpenter; Erik A Imel; Ingrid A Holm; Suzanne M Jan de Beur; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2011-05-02       Impact factor: 6.741

Review 5.  Renal osteodystrophy.

Authors:  Nirmal C Tejwani; Aaron K Schachter; Igor Immerman; Pramod Achan
Journal:  J Am Acad Orthop Surg       Date:  2006-05       Impact factor: 3.020

6.  Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.

Authors:  Guoying Liang; Lee D Katz; Karl L Insogna; Thomas O Carpenter; Carolyn M Macica
Journal:  Calcif Tissue Int       Date:  2009-07-17       Impact factor: 4.333

7.  The development of a short measure of physical function for knee OA KOOS-Physical Function Shortform (KOOS-PS) - an OARSI/OMERACT initiative.

Authors:  A V Perruccio; L Stefan Lohmander; M Canizares; A Tennant; G A Hawker; P G Conaghan; E M Roos; J M Jordan; J-F Maillefert; M Dougados; A M Davis
Journal:  Osteoarthritis Cartilage       Date:  2008-02-21       Impact factor: 6.576

8.  Pain and recovery after total knee arthroplasty: a 12-month follow-up after a prospective randomized study evaluating Nefopam and Ketamine for early rehabilitation.

Authors:  Christophe Aveline; Alain Le Roux; Hubert Le Hetet; Jean F Gautier; Pierre Vautier; Fabrice Cognet; Francis Bonnet
Journal:  Clin J Pain       Date:  2014-09       Impact factor: 3.442

9.  Hip and knee arthroplasty in hypophosphatemic rickets.

Authors:  A Noelle Larson; Robert T Trousdale; Mark W Pagnano; Arlen D Hanssen; David G Lewallen; Joaquin Sanchez-Sotelo
Journal:  J Arthroplasty       Date:  2009-08-12       Impact factor: 4.757

Review 10.  Latest findings in phosphate homeostasis.

Authors:  Dominique Prié; Pablo Ureña Torres; Gérard Friedlander
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612
View more
  6 in total

Review 1.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 2.  Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.

Authors:  Andrea Trombetti; Nasser Al-Daghri; Maria Luisa Brandi; Jorge B Cannata-Andía; Etienne Cavalier; Manju Chandran; Catherine Chaussain; Lucia Cipullo; Cyrus Cooper; Dieter Haffner; Pol Harvengt; Nicholas C Harvey; Muhammad Kassim Javaid; Famida Jiwa; John A Kanis; Andrea Laslop; Michaël R Laurent; Agnès Linglart; Andréa Marques; Gabriel T Mindler; Salvatore Minisola; María Concepción Prieto Yerro; Mario Miguel Rosa; Lothar Seefried; Mila Vlaskovska; María Belén Zanchetta; René Rizzoli
Journal:  Nat Rev Endocrinol       Date:  2022-04-28       Impact factor: 43.330

3.  Inhibition of FGFR Signaling Partially Rescues Osteoarthritis in Mice Overexpressing High Molecular Weight FGF2 Isoforms.

Authors:  Liping Xiao; Donyell Williams; Marja M Hurley
Journal:  Endocrinology       Date:  2020-01-01       Impact factor: 4.736

Review 4.  Congenital Conditions of Hypophosphatemia in Children.

Authors:  Erik Allen Imel
Journal:  Calcif Tissue Int       Date:  2020-04-23       Impact factor: 4.333

5.  Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia.

Authors:  Gabriel T Mindler; Andreas Kranzl; Alexandra Stauffer; Roland Kocijan; Rudolf Ganger; Christof Radler; Gabriele Haeusler; Adalbert Raimann
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-27       Impact factor: 5.555

6.  Giving Credence to the Experience of X-Linked Hypophosphatemia in Adulthood: An Interprofessional Mixed-Methods Study.

Authors:  Melissa Hughes; Carolyn Macica; Catherine Meriano; Maya Doyle
Journal:  J Patient Cent Res Rev       Date:  2020-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.